Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron prophylaxis in pregnancy – is ferroamino-chelate more effective than ferrous sulfate?
2007-003061-40Phase 4Completed
- Sponsor
- Næstved Sygehus
- Start
- Jan 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferrous bisglycinate and ferrous sulfate in iron deficiency anemia (IDA) and pregnancy (3 arms), sponsored by Næstved Sygehus. Primary endpoint: Prevention of iron deficiency by gestational week 36–37. Started Jan 2008; status: completed.
02
Drugs
ferrous bisglycinateferrous sulfate
03
Conditions
iron deficiency anemia (IDA)pregnancy
Beyond the preview
Go deeper on 2007-003061-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003061-40.